Fosun Pharmaceu...
login
Shares
Bonds
π₯Pre-IPO
Dividends
Portfolio
More
ETF
Sectors
News
Calendar
Try for free
Login
×
Email
Password
Forgot your password?
Login
Resend my activation email
Need an account? Sign up.
Home
News
Concert Pharmaceuticals
Fosun Pharmaceutical bought Concert Pharmaceuticals
1/19/23 at 17:11
Share at
Vladimir Petenev
News editor
press@blackterminal.com
Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.
Concert Pharmaceuticals
Review
Source:
ir.concertpharma.com
Vladimir Petenev
News editor
Share at:
Share this news
×
To leave a comment, you must be logged in
Write your comment first
News feed
Yakovlev reported for 2024 by RAS
2/3/25
IRKT
Board of Directors of Diasoft recommended dividends
2/3/25
DIAS
Positive Technologies will lay off about 500 IT professionals
2/3/25
POSI
Seligdar received a license for geological exploration at the Fedorovskaya area
2/3/25
SELG
Russneft replenished production by 171%
2/3/25
RNFT
Aeroflot reported for 2024 by RAS
2/3/25
AFLT
Cherkizovo reports for 2024 by RAS
2/3/25
GCHE
Severstal will not pay dividends for Q4 2024
2/3/25
CHMF
Severstal reports for 2024 by IFRS
2/3/25
CHMF
Severstal's capex in 2025 will be β½169 billion
2/3/25
CHMF
«
Previous
21
22
23
24
25
26
27
28
29
30
»
Next
BlackTerminal.com 2016 - 2025.
English (US)
English (US)
Π ΡΡΡΠΊΠΈΠΉ (Π Π€)
ir.concertpharma.com ir.concertpharma.com ir.concertpharma.com
English (US) 